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Abstract
Background: Differentiated cells can be reprogrammed into pluripotency by transduction of four defined transcription
factors. Induced pluripotent stem cells (iPS cells) are expected to be useful for regenerative medicine as well as basic
research. Recently, the report showed that mouse embryonic fibroblasts (MEF) cells are not essential for reprogramming.
However, in using fibroblasts as donor cells for reprogramming, individual fibroblasts that had failed to reprogram could
function as feeder cells.
Methodology/Principal Finding: Here, we show that adult mouse neural stem cells (NSCs), which are not functional feeder
cells, can be reprogrammed into iPS cells using defined four factors (Oct4, Sox2, Klf4, and c-Myc) under feeder-free
conditions. The iPS cells, generated from NSCs expressing the Oct4-GFP reporter gene, could proliferate for more than two
months (passage 20). Generated and maintained without feeder cells, these iPS cells expressed pluripotency markers (Oct4
and Nanog), the promoter regions of Oct4 and Nanog were hypomethylated, could differentiated into to all three germ
layers in vitro, and formed a germline chimera. These data indicate that NSCs can achieve and maintain pluripotency under
feeder-free conditions.
Conclusion/Significance: This study suggested that factors secreted by feeder cells are not essential in the initial/early
stages of reprogramming and for pluripotency maintenance. This technology might be useful for a human system, as a
feeder-free reprogramming system may help generate iPS cells of a clinical grade for tissue or organ regeneration.
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Introduction
Pluripotent embryonic stem (ES) cells not only have potential to
differentiate into all three germ layers but also ability to self-renew
for an expanded period of time [1]. These capabilities of
pluripotent stem cells are expected to be useful for regenerative
medicine as well as basic research [2,3]. However, ethical issues
have shackled the clinical applications of ES cells. Yamanaka and
colleagues showed that a noble source of pluripotent stem cells
could be directly derived from differentiated somatic cells by
transduction of reprogramming factors [4]. The induced plurip-
otent stem (iPS) cells were generated by transduction of four
defined transcription factors (Oct4, Sox2, Klf4, and c-Myc) from
mouse and human somatic cells [4–7]. These iPS cells were
indistinguishable from ES cells in expression of pluripotency-
associated genes and differentiation potential in vitro and in vivo [8–
11].
Mouse embryonic fibroblasts (MEFs) have been used as a feeder
cells to support ES cell derivation and iPS cell generation.
Pluripotent ES cells have been derived from the inner cell mass
(ICM) of blastocysts and can be expanded in vitro in a culture with
inactivated MEF feeder cells [12–14]. Differentiated cells have
been reprogrammed on MEF feeder cells, which provide a
reprogramming microenvironment for generating iPS cells.
However, recent reports indicate that the iPS cells were induced
to differentiate when cultured in the absence of feeder cells [4,7],
suggesting that MEF feeder cells provide a supportive reprogram-
ming environment [4,9]. MEF feeder cells secret multiple proteins
and soluble factors, such as Activin A, TGF ß, WNT, and BMP4,
which are important in maintaining proliferation and pluripotency
of ES cells [15,16]. However, MEF and human fibroblast feeder
cells are inactivated by irradiation and mitomycin C, treatment
that may cause DNA damage to pluripotent stem cells and the
chemical of which may persist in the culture system after extensive
washing [17].
Therefore, future application involving iPS cell–derived cells or
tissues in human is contingent upon the ability of a feeder–free
culture system to support the long-term stability of cell lines. Thus,
many researchers have attempted to induce and maintain
pluripotency of iPS cells in a feeder-free culture system in mouse
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were not necessary for the initial step of reprogramming, but were
important for maintaining iPS cell proliferation [20]. However, in
the reprogramming culture, individual fibroblasts that had failed
to reprogram could function as feeder cells [24] and support
reprogrammed cells. Those authors did not verify whether the iPS
cells cultured in the feeder-free condition are functionally
pluripotent, either by showing chimera formation after blastocyst
injection or by aggregation methods.
In this study, we demonstrated that a feeder cell is not essential
for reprogramming somatic cells into iPS cells and maintaining iPS
cell pluripotency. To investigate whether iPS cells could be
generated and maintained without feeder cells, we generated iPS
cells from mouse neural stem cells (NSCs), which served as the
somatic cell source. These NSC-derived iPS (NSC-iPS) cells
expressing Oct4-GFP proliferated for at least for 20 passages.
Feeder-free NSC-iPS cells showed expression of pluripotency-
related genes, pluripotential epigenetic state, differentiation
potential into all three germ layers in vitro, and formation of
germline chimeras. Our finding demonstrates that NSCs can be
reprogrammed into germline-competent iPS cells under feeder-
free conditions.
Materials and Methods
NSCs culture
We used mouse neural stem cells (NSCs) as a somatic cells for
reprogramming. NSCs were derived from OG2/ROSA26
heterozygous double transgenic mice, which were generated by
crossing ROSA26 (carrying neo/lacZ transgene) strain with OG2
transgenic strain (carrying GFP under the control of the Oct4
promoter, Oct4-GFP) over several generations. Brain tissue was
collected from 12.5- to 16.5-day post coitum (dpc) fetuses, which
were OG2/ROSA26 heterozygous double transgenic. Neuro-
spheres cultured from the brain tissues were prepared as
described in detail in the previous report [25]. The cortex was
dissected from the rest of the brain of each mouse and
enzymatically dissociated in HBSS (with 2 mM glucose) contain-
ing 0.7 mg/ml hyaluronic acid, 0.2 mg/ml kynurenic acid, and
1.33 mg/ml trypsin at 37uC for 30 min. The dissociated cells
were passed through a 70-mm nylon mesh (Falcon) to remove
large cell clusters. The cells were then centrifuged at 200 g for
5 min and collected by centrifugation in 0.9 M sucrose in 0.5X
HBSS at 750 g for 10 min. The cell pellet was resuspended in
2 ml of culture medium, placed on top of 10 ml of 4% bovine
serum albumin (BSA) in EBSS solution, and centrifuged at 200 g
for 7 min. The culture medium was supplemented with 20 ng/ml
epidermal growth factor (EGF; Gibco BRL), 20 ng/ml basic
fibroblast growth factor (bFGF), B27 supplement (Gibco BRL),
8 mM HEPES, 2 mM glutamine, 100 U/ml penicillin, and
100 mg/ml streptomycin in DMEM-F12 medium (Gibco BRL).
Primary neurospheres were replated onto gelatinized dishes in
NSC expansion medium: NS-A media (Euroclone) supplemented
with N2 supplement, 10 ng/ml of EGF, and bFGF (Invitrogen),
50 mg/ml bovine serum albumin (BSA Fraction V; Gibco BRL),
1X penicillin/streptomycin/glutamine, and 1X nonessential
amino acids (Gibco BRL). Outgrowing cells were trypsinized,
replated, and cultured in NSC expansion medium. NSCs were
established by dissociation and replated onto gelatin-coated
dishes in NSC expansion medium.
Generation of iPS cells from NSCs
pMX-based retroviral vectors encoding the mouse cDNAs of
Oct4, Sox2, KLf4, and c-Myc [4] were separately co-transfected by
packaging defective helper plasmids into 293T cells using Fugene
6 transfection reagent (Roche). 48 hrs post-infection, virus
supernatants were collected, filtered, and concentrated as
previously described [26]. NSCs (OG2
+/2/ROSA26
+/2) were
seeded at a density of 1610
5 cells per 6-well plate and incubated
with virus-containing supernatants of the four factors (1:1:1:1)
supplemented with 6 mg/ml protamine sulfate (Sigma) for 24 hrs.
On day 7 after viral infection, GFP-positive colonies were
transferred onto gelatin coated dishes, and then trypsinized,
replated, and cultured in two different types of ES cell media:
typical DMEM-based medium supplemented with 15% fetal
bovine serum (FBS), 1X penicillin/streptomycin/glutamine,
0.1 mM nonessential amino acids, 1 mM b-mercaptoethanol
(Gibco BRL), and 10
3 units/ml leukemia inhibitor factor (LIF;
ESGRO, Chemicon International); and feeder-free GMEM-based
mediumsupplemented with 15%FBS,1Xpenicillin/streptomycin/
glutamine, 0.1 mM nonessential amino acids, 1 mM b-mercapto-
ethanol, and 10
3 units/ml LIF.
RNA isolation and quantitative RT-PCR
Total RNA was isolated using the RNeasy Mini Kit (QIAGEN)
and treated with DNase to remove genomic DNA contamination.
1 mg of total RNA was reverse transcribed with SuperScript III
Reverse Transcriptase Kit (Invitrogen) and Oligo(dT) primer
(Invitrogen) according to the manufacturer’s instructions. Quan-
titative polymerase chain reaction (PCR) reactions were set up in
duplicate with the Power SYBR Green Master Mix (Dakara) and
analyzed with the Roche LightCycler 5480 (Roche). Primers used
are listed in Table 1.
Bisulfite DNA sequencing analysis
To differentiate the methylated from the unmethylated CG
dinucleotides, genomic DNA was treated with sodium bisulfite to
convert all unmethylated cytosine residues into uracil residues
using EpiTect Bisulfite Kit (QIAGEN) according to the manufac-
turer’s protocol. Briefly, purified genomic DNA (0.5–1 mg) was
denaturated at 99uC and then incubated at 60uC. Modified
DNA—i.e. after desulfonation, neutralization, and desalting—was
diluted with 20 ml of distilled water. Subsequently, bisulfite PCR
(BS-PCR) amplification was carried out using 1–2 ml aliquots of
modified DNA for each PCR reaction.
PCR amplification for the promoter regions of Oct4 and Nanog
was done as previously described [27]. Briefly, the amplified
products were verified by electrophoresis on 1% agarose gel. The
desired PCR products were used for subcloning using TA cloning
vector (pGEM-T Easy Vector; Promega). The reconstructed
plasmids were purified, and individual clones were sequenced
(Solgent Coporation). Clones with $ 90% cytosine conversion
were accepted, and all possible clonalities were excluded based on
criteria from BiQ Analyzer software (Max Planck Society). Primers
used are listed in Table 1.
In-vitro differentiation of iPS cells and
immunofluorescence assay
Differentiation of iPS cells cultured without feeder cells was
induced by treatment with retinoic acid (RA). iPS cells were
transferred into a suspension culture dish after trypsinization and
cultured for 2 days with DMEM (10% FBS) in the absence of LIF.
After 2 days, emerging embryoid bodies were treated with 5 mM
RA for 8 days in the suspension culture dish and then plated onto
a gelatin-coated dish for 10 days. Cells that had differentiated from
iPS cells were stained for markers of the three germ layers makers:
HNF 3ß for endoderm, Brachyury for mesoderm, and Tuj1 for
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paraformaldehyde for 20 min at room temperature. After washing
with PBS, cells were treated with PBS containing 10% normal
goat serum and 0.03% Triton X-100 for 45 min at room
temperature. Primary antibodies used were anti–ß III tubulin
(Tuj1; monoclonal, 1:1000, Chemicon, Temecula, CA, USA),
anti-Brachyury (Brachyury; polyclonal, 1:1000, Chemicon), and
hepatocyte necrosis factor (HNF 3b; monoclonal, 1:1000,
Chemicon). For detection of primary antibodies, fluorescence-
labeled (Alexa fluor 488 or 568; Molecular Probes, Eugene, OR,
USA) secondary antibodies were used according to the specifica-
tions of the manufacturer.
Aggregation of iPS cells with zona-free embryos
iPS cells were aggregated with denuded post-compacted eight-
cell–stage embryos to obtain an aggregate chimera. Eight-cell
embryos flushed from 2.5-dpc B6D2F1 female mice were cultured
in microdops of embryo culture medium under mineral oil. After
cells were trypsinized for 10 seconds, clumps of iPS cells (4–10
cells) were selected and transferred into microdrops containing
zona-free eight-cell embryos. Morula-stage embryos aggregated
with feeder-free (FF)-iPS cells were cultured overnight at 37 uC,
5% CO2. The aggregated blastocysts were transferred into one
uterine horn of 2.5-dpc pseudopregnant recipients. Animals were
maintained and used for experimentsation under the guidelines of
the Institutional Animal Care and Use Committee of Max-Planck
Institute for Molecular Biomedicine and CHA University.
Institutional review board or ethics committee specifically
approved this study (IACUC 090003).
X-gal staining
For whole fetal embryo staining, collected fetuses were rinsed
with PBS and fixed with 4% formaldehyde for 1 hr at 4uC.
Fetuses were rinsed three times at room temperature in PBS
supplemented with 5 mM EGTA, 0.01% deoxycholate, 0.02%
NP40, and 2 mM MgCl2. The specimens were washed with PBS
and then stained in X-gal staining solution: PBS supplemented
with 1 mg/ml 5-bromo-4-chloro-3-indolyl-galactosidase (X-gal;
Promega, Madison, WI, USA), 5 mM K2Fe(CN)6,5 m M
K4Fe(CN)6, and 1 mM MgCl2. Blue staining was visualized by
light microscopy.
Results
Generation of iPS cells from NSCs in a feeder-free
condition
We used NSCs obtained from OG2/ROSA26 heterozygous
male brain tissue as donor cells for reprogramming experiments.
Therefore, these NSCs contain Oct4-GFP and neo/LacZ trans-
genes. The Oct4 gene is expressed in pluripotent cells of the
mouse embryo up to the gastrulation stage [27–29] and is
restricted to germ cells thereafter [30]. Oct4, which is inactive in
NSCs, becomes reactivated when NSCs are reprogrammed into
pluripotent cells [25]. We first tested whether NSCs could
achieve a state of pluripotency without feeder cells in the culture.
NSCs were transduced by four transcription factors encoding
Oct4, Sox2, Klf4, and c-Myc and cultured on feeder cells (MEFs)
or without feeder cells. Oct4-GFP–positive colonies were first
detected on day 8 after viral infection both in culture without
Table 1. Primers and reaction conditions used in qRT-PCR and bisulfite sequencing analysis.
Gene Tm (6C) Sequence 59-39 Size (bp) Application Accenssion No.
Oct4 (endo) 60 cca atc agc ttg ggc tag ag 129 qRT-PCR NM_013633
ctg gga aag gtg tcc ctg ta
Sox2 (endo) 60 cac aac tcg gag atc agc aa 190 qRT-PCR NM_011443
ctc cgg gaa gcg tgt act ta
Nanog (endo) 60 agg ctg att tgg ttg gtg tc 205 qRT-PCR NM_028016
ccc agg aag acc cac act cat
Oct4 1st 45 ttt gtt ttt tta ttt att tag ggg g 299 BGS NM_013633
atc ccc aat acc tct aaa cct aat c
Oct4 2nd 55 ggg tta gag gtt aag gtt aga ggg 161 BGS NM_013633
ccc cca cct aat aaa aat aaa aaa a
Nanog 1st 45 ttt gta ggt ggg att aat tgt gaa 312 BGS NM_028016
aaa aaa ttt taa aca aca acc aaa aa
Nanog 2nd 55 ttt gta ggt tgg gat taa ttg tga a 188 BGS NM_028016
aaa aaa aca aaa cac caa cca aat
Oct4 TG 65 gac ggc atc gca gct tgg ata 320 RT-PCR N/A
cca ata cct ctg agc ctg gt
Sox2 TG 65 gac ggc atc gca gct tgg ata 442 RT-PCR N/A
cgc ttg gcc tcg tcg atg aa
Klf4 TG 65 gac ggc atc gca gct tgg ata 308 RT-PCR N/A
ggg aag tcg ctt cat gtg ag
c-Myc TG 65 gac ggc atc gca gct tgg ata 399 RT-PCR N/A
acc gca aca tag gat gga ga
qRT-PCR: Quantitative RT-PCR, BGS: Bisulfite genomic sequencing, N/A: Not applicable.
doi:10.1371/journal.pone.0021367.t001
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of Oct4-GFP of NSCs did not require feeder cells. The number of
Oct4-GFP–positive colonies from monolayer NSCs or on feeder
cells was counted on days 8, 15, and 22 after viral infection.
Reprogramming efficiency of NSCs cultured on feeder cells was
three times higher than that for NSCs cultured without feeder
cells (Fig. 1a). These results suggested that initial reactivation of
Oct4-GFP of NSCs does not require feeder cells but that feeder
cells support maintenance of pluripotency and proliferation of
iPS cells.
Oct4-GFP–positive cells were collected and transferred onto a
gelatin-coated dish and cultured in two different types of ES cell
medium: typical medium (DMEM-based) and feeder-free
medium (GMEM-based) (Fig. 1b). GFP-positive iPS cells plated
onto a gelatin-coated dish formed flat colonies, but ES cells
cultured on feeder cells formed dome-like colonies. Feeder-free
NSC-iPS cells (FF-iPS cells) maintained pluripotency (judged by
Oct4-GFP expression) in GMEM-based medium but not in
DMEM-based medium. In DMEM-based medium, the number
of Oct4-GFP–positive cells gradually declined until the cells all
disappeared (Figure S1), indicating that iPS cells did not
maintain pluripotency but were induced to differentiate in a
feeder-free condition. FF-iPS cells cultured in GMEM-based
medium expressed Oct4-GFP and could proliferate for more than
two months (passage 20); in addition, the morphology of FF-iPS
cell colonies was similar to that of ES cell colonies cultured on
feeder cells (Fig. 1b). Taken together, these results suggest that
NSCs can achieve pluripotency by defined factors and the
resultant iPS cells can maintain ES cell–like morphology under
feeder-free conditions.
Figure 1. Generation and Cultivation of iPS cells from NSCs Without Feeder Cells. (a) NSCs transduced by four factors were cultured on
monolayer without feeder cells or on feeder cells (MEFs), and the number of GFP-positive colonies was counted on days 8, 15, and 22 after viral
infection. (b) Phase and fluorescence (GFP) images of FF-iPS cells from NSCs cultured in a feeder-free system with GMEM-based ES cell medium at
passages 0, 1, and 13.
doi:10.1371/journal.pone.0021367.g001
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reprogramming in FF-iPS cells
We performed real-time RT-PCR analysis to determine the
expression level of pluripotency-related genes, Oct4 and Nanog,i n
FF-iPS cells (Fig. 2a). FF-iPS cells expressed similar levels of these
pluripotency markers to ES and iPS cells, which were cultured on
feeder cells. However, retroviral transgenes were silenced in FF-
iPS cells (Fig. 2b). Next, we assessed the DNA methylation status of
Oct4 and Nanog in FF-iPS cells. Bisulfite genomic sequencing
analysis revealed that the promoter regions of these two genes
were unmethylated in FF-iPS cells, as shown in pluripotent ES
cells (Fig. 2c). However, these regions were hypermethylated in
NSCs (Fig. 2c). These results demonstrate that the expression
levels and epigenetic status of pluripotency genes in FF-iPS cells
are similar to those in ES cells.
In-vitro and in-vivo differentiation potential of FF-iPS
cells
To investigate the differentiation potential of FF-iPS cells in vitro,
we determined whether FF-iPS cells could differentiate into three
germ layers by embryoid body (EB) differentiation. Well-formed
EB structures were observed on day 8 of culture of FF-iPS cells in
the absence of LIF (Fig. 3a). These EBs were incubated on a
gelatin-coated tissue plate and cultured in MEF medium for 10–15
days. Immunocytochemical analysis showed that FF-iPS cells had
differentiated into all three germ layers tissues: ectodermal (Tuj1),
mesodermal (Brachyury), and endodermal lineages (HNF 3ß)
(Fig. 3b–d). To investigate the in-vivo developmental differentiation
potential of FF-iPS cells, we performed aggregation analysis. FF-
iPS cells had incorporated into the ICM of a normal embryo after
aggregation with zona-free morula embryos (Fig. 4a). When the
blastocysts were transferred into the uterus of pseudopregnant
mice, the FF-iPS cells formed chimeric embryos (13.5 dpc),
showing germline contribution (Fig. 4b–c). Taken together, these
results demonstrate that FF-iPS cells possess pluripotent differen-
tiation and developmental potential in vitro and in vivo.
Discussion
In the present study, we showed that iPS cells can be induced
from NSCs by defined transcription factors and maintained in a
Figure 2. Pluripotency Marker Expression Levels and Methylation Pattern in FF-iPS cells. (a) Expression levels of endogenous factors
(Oct4, Sox2, Nanog) quantified by real-time-PCR. (b) RT-PCR analysis for retroviral transgenes. (c) Bisulfite genomic sequencing of the promoter
regions of Oct4 and Nanog.
doi:10.1371/journal.pone.0021367.g002
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PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e21367Figure 3. In-vitro Differentiation Potential of FF-iPS Cells. (a) FF-iPS cells could form embryoid bodies (EBs). Immunofluorescence analyses
show expression of markers for neuroectoderm (Tuj1; red) (b), mesoderm (Brachyury; red) (c), endoderm (HNF 3ß; red) (d).
doi:10.1371/journal.pone.0021367.g003
Figure 4. In-vivo Differentiation Potential of FF-iPS Cells. (a) The aggregated embryo shows that FF-iPS cells were incorporated into inner cell
mass (ICM) of a normal embryo (Oct4-GFP–positive cells in ICM). (b) FF-iPS cells could contribute to germline cell development (Oct4-GFP–positive) in
a male gonad (13.5 dpc). (c) Chimeric embryo of FF-iPS cells was stained by X-gal.
doi:10.1371/journal.pone.0021367.g004
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least for 20 passages, maintaining a cellular state of pluripotency
and differentiation potential into all three germ layers in vitro and in
vivo. These FF-iPS cells expressed similar levels of pluripotency-
related genes to ES cells and the promoter regions of Oct4 and
Nanog were hypomethylated in FF-iPS cells. FF-iPS cells could
form EBs, which could differentiate into derivates of the three
embryonic germ layers. Moreover, FF-iPS cells have passed the
stringent test for pluripotency by generating germline chimeras.
Chen et al. suggested that the efficiency of iPS cell generation
without feeder cells was not different from that of reprogramming
on feeder cells [20]. However, in this study, we showed that
efficiency of reprogramming induced on feeder cells was three
times higher than that without feeder cells (Fig. 1a), indicating that
feeder cells support self-renewal and pluripotency of early-stage
reprogrammed cells. Discrepancy in these results may be due to
the types of somatic cells that are used for reprogramming. In
using fibroblasts as donor cells, individual fibroblasts that had
failed to reprogram could function as feeder cells and support
those fibroblast cells that had been successfully reprogrammed. By
using NSCs as donor cells, we could eliminate the possibility of any
support from donor cells, as ES cells display a tendency to
differentiate (data not shown), thus indicating that NSCs do not
function as feeder cells.
NSCs are efficiently reprogrammed into a pluripotent state in a
nuclear reprogramming system, such as cell-cell fusion and direct
reprogramming [31,32]. The fact that NSCs which already
express Sox2 and c-Myc could acquire pluripotency by only one
factor, Oct4, suggests that NSCs may exist in an intermediate state
between differentiated and pluripotent stem cells [33]. In this
study, Oct4-GFP was detected on day 7 after retroviral infection
(Oct4, Sox2, Klf4, and c-Myc) without feeder cells. NSCs achieved
pluripotency (judged by activation of Oct4-GFP) as early as the
control group (on day 8 after infection) when cultured on feeder
cells, indicating that the feeder cell is not a crucial factor in the
initial step/stages of reprogramming. However, in a drug-
inducible system, neural stem/progenitor cells could be repro-
grammed only with feeder cells [19]. Although there is no clear
explanation for this, feeder dependency may be affected not only
by the somatic cell type, but also by the reprogramming-inducing
method.
We demonstrated that iPS cells reprogrammed from NSCs
could maintain pluripotency in a feeder-free system. In typical
DMEM-based medium, the Oct4-GFP–positive cells gradually
disappeared, as they differentiated. However, previous reports
have shown that conditioned medium containing factors secreted
by MEFs [16,34] could support maintenance of pluripotency [35–
38]. So we tested whether MEF-conditioned medium supports
pluripotency maintenance of iPS cells in a feeder-free culture
system. When the FF-iPS cells were cultured in a mixture of
DMEM-based ES cell medium and MEF-conditioned medium
(1:1), Oct4-GFP–positive cells disappeared as early as those in
typical DMEM-based ES cell medium. Mouse ES cells are
generally cultured in DMEM-based medium with feeder cells, in
which mouse ES cells form domed colonies. Mouse ES cells also
can be cultured in GMEM-based ES medium without feeder cells,
in which ES cells form flat colonies. However, GMEM-based
medium is used only for specific ES cell line, such as HM-1 and
nanog overexpressing cell line [32,39]. Interestingly, we found that
NSC derived iPS cells maintained Oct4-GFP expression for more
than two months (passage 20) and form domed colonies in
GMEM-based ES medium without feeder cells. Collectively, these
data indicate that GMEM-based medium is more effective for
cultivation of mouse iPS cells in a feeder-free system than typical
DMEM-based medium or MEF-conditioned medium.
It has been suggested that in feeder-free system, the pluripo-
tency of ES and iPS cells could be maintained in conditioned-
medium [40] or by chemical support [35,41]. Our study
demonstrated that NSCs, which do not function as a feeder cells,
were successfully reprogrammed into a pluripotent state and could
maintain pluripotency without feeder cells in a simple GMEM-
based medium, indicating that factors secreted by feeder cells are
not essential in the initial/early stages of reprogramming and for
pluripotency maintenance.
Supporting Information
Figure S1 Spontaneous Differentiation of FF-iPS Cells
in Typical ES Cell Medium. Phase contrast and fluorescence
(GFP) images of FF-iPS from NSCs differentiated in a feeder-free
system with typical ES cell medium at passages 1, 3, and 13.
(TIF)
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